IBDEI0YS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17170,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,17170,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,17171,0)
 ;;=490.^^92^949^18
 ;;^UTILITY(U,$J,358.3,17171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17171,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,17171,1,5,0)
 ;;=5^Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,17171,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,17172,0)
 ;;=682.8^^92^949^21
 ;;^UTILITY(U,$J,358.3,17172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17172,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,17172,1,5,0)
 ;;=5^Cellulitis NEC
 ;;^UTILITY(U,$J,358.3,17172,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,17173,0)
 ;;=585.9^^92^949^22
 ;;^UTILITY(U,$J,358.3,17173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17173,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,17173,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,17173,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,17174,0)
 ;;=428.0^^92^949^19
 ;;^UTILITY(U,$J,358.3,17174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17174,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,17174,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,17174,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,17175,0)
 ;;=496.^^92^949^20
 ;;^UTILITY(U,$J,358.3,17175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17175,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,17175,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,17175,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,17176,0)
 ;;=414.01^^92^949^23
 ;;^UTILITY(U,$J,358.3,17176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17176,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,17176,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,17176,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,17177,0)
 ;;=311.^^92^949^25
 ;;^UTILITY(U,$J,358.3,17177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17177,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,17177,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,17177,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,17178,0)
 ;;=250.01^^92^949^26
 ;;^UTILITY(U,$J,358.3,17178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17178,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,17178,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,17178,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,17179,0)
 ;;=250.00^^92^949^27
 ;;^UTILITY(U,$J,358.3,17179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17179,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,17179,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,17179,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,17180,0)
 ;;=305.90^^92^949^29
 ;;^UTILITY(U,$J,358.3,17180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17180,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,17180,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,17180,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,17181,0)
 ;;=305.93^^92^949^28
 ;;^UTILITY(U,$J,358.3,17181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17181,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,17181,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,17181,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,17182,0)
 ;;=796.2^^92^949^33
 ;;^UTILITY(U,$J,358.3,17182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17182,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,17182,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,17182,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,17183,0)
 ;;=607.84^^92^949^35
 ;;^UTILITY(U,$J,358.3,17183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17183,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,17183,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,17183,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,17184,0)
 ;;=530.81^^92^949^36
 ;;^UTILITY(U,$J,358.3,17184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17184,1,4,0)
 ;;=4^530.81
